This two-vial research set supplies Retatrutide (LY3437943) and MOTS-c as two separate 10mg lyophilized vials. The two compounds are studied in adjacent rather than overlapping metabolic literature: Retatrutide at the GLP-1, GIP, and glucagon receptors, and MOTS-c as a mitochondrial-derived peptide reported to act upstream through AMPK. For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.
Retatrutide + MOTS-C research bundle from Maple Research Labs. Two research peptides in one discounted package for qualified investigators.
1x Retatrutide 10MG (CAS: 2381089-83-2) — published COA for a tested sample
1x MOTS-C 10MG (CAS: 1627580-64-6) — published COA for a tested sample
Individual Value: $159.00 CAD
Bundle Price: $143.10 CAD (Save 10%)
Research Context
This bundle pairs two compounds studied across distinct but complementary research domains. Retatrutide is a triple agonist peptide (GIP/GLP-1/glucagon receptors) investigated in preclinical and clinical metabolic research. MOTS-C is a mitochondrial-derived peptide studied for its role in cellular energy metabolism and AMPK pathway activation in laboratory models.
Both compounds are supplied as lyophilized powder in individually sealed, labeled vials. Published COAs describe tested samples from independent third-party laboratories; a report does not establish every vial or current shipping-lot coverage. Lab locations are those stated on each report.
Certificates of Analysis
This is a bundle of separate vials, not a blend. Each compound is analysed on its own and has its own COA. Third-party certificates of analysis for tested samples are published on our COA page. Check the report’s compound, tested size, date and method. Vials do not carry printed lot or batch numbers. One certificate never covers two different compounds unless they are supplied premixed in a single vial as a blend.
Purity: 99.6% (HPLC-MS/MS)
Report: COA-2026-SC-01772 · report lot field 082126
COA Download: View Full COA (PDF)
Verify: laboratory verification page for this report
Purity: 99.69% HPLC-UV relative-area on published tested sample
Report: DBAV-MOTS-10-051226-02
COA Download: View Full COA (PDF)
Third-party HPLC testing by independent third-party laboratories. The method for each tested sample is stated on its report. A report does not establish every vial or lot.
Storage
Store lyophilized peptides at -20°C for long-term storage.
Shipping
In-stock orders paid by 2 PM PT (Mon–Fri) ship the same business day, from BC with tracking. Ships from Canada via tracked domestic shipping.
Disclaimer: For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use. Must be 19+ to purchase. By purchasing, you agree that this product will be used exclusively for legitimate research purposes.
For peer-reviewed research on this topic, visit PubMed.
Related Research Reading
Mechanistic background for each component is covered in Retatrutide triple receptor agonism and MOTS-c mitochondrial-derived signalling and AMPK activation. Third-party analytical documentation is published on the Certificates of Analysis page.
Join the research list
New arrivals, current pricing, and research breakdowns, every few days. Unsubscribe anytime.
Maple 





